Dermatologic Manifestations of Homocystinuria Treatment & Management
- Author: Janette Baloghova, MD, PhD; Chief Editor: Dirk M Elston, MD more...
The diagnosis should be established as early as possible. Neonates in whom homocystinuria is diagnosed have had a benign course when they are fed on methionine-restricted cysteine-supplemented diets. Cysteine can be supplemented to a maximum of 500 mg/d.
The administration of pyridoxine in high doses (300-600 mg/d) is effective in some patients.
Other possible treatments include the use of folic acid (in pharmacologic doses), betaine (3-methylglycine decreases serum concentrations of homocysteine), or cyanocobalamin, as well as symptomatic supportive measures.
Homocysteine Reduction Formula, a special nutritional supplement created by Brimhall, can also lower homocysteine levels.
In patients with hypothyroidism, treatment with L-thyroxine can normalize homocysteine levels.
Betaine improves metabolic control in B6-nonresponsive patients with homocystinuria after optimum dietary control.[57, 58, 59]
Betaine therapy can precipitate cerebral edema, although the exact mechanism is uncertain. Betaine does raise the methionine level, and cerebral edema can occur when plasma methionine values exceed 1000 µmol/L. Methionine levels must be monitored in patients with cystathionine beta-synthase deficiency who are on betaine; consider betaine as an adjunct, not an alternative, to dietary control.[60, 61]
However, even when patients' serum betaine concentrations are increased by supplementation, serum homocysteine concentrations are often not lowered to the reference range. Following a low-methionine diet that keeps serum methionine within the reference range may be necessary when treating patients with homocystinuria due to cystathionine beta-synthase deficiency when betaine is administered.
Conventional treatment of cystathionine beta-synthase deficiency by diet and pyridoxine/betaine normalizes many, but not all, metabolic abnormalities associated with cystathionine beta-synthase deficiency. The finding of low plasma serine concentrations in patients with untreated cystathionine beta-synthase deficiency may merit further exploration because supplementation with serine might be a novel and safe component of treatment of homocystinuria.
Surgical treatment should be considered, especially in patients with pupillary-block glaucoma or in those with recurrent lens dislocation into the anterior chamber. Other ophthalmologic or orthopedic disorders should be corrected.
An ophthalmologist should be consulted for the treatment of repeated lens dislocation, acute pupillary-block glaucoma, and other ophthalmologic disorders.
An orthopedist should be consulted to correct orthopedic disorders.
Patients must maintain a diet with limited amounts of protein (1 g/kg) and amino acid mixtures. The diet must be free of protein hydrolysate.
Patients in whom the disease does not respond to pyridoxine supplements must be treated with dietary reductions in methionine and with cysteine supplementation.
Mudd SH, Skovby F, Levy HL, et al. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet. 1985 Jan. 37(1):1-31. [Medline].
Finkelstein JD. Inborn errors of sulfur-containing amino acid metabolism. J Nutr. 2006 Jun. 136(6 Suppl):1750S-1754S. [Medline].
Vyletal P, Sokolova J, Cooper DN, et al. Diversity of cystathionine beta-synthase haplotypes bearing the most common homocystinuria mutation c.833T>C: a possible role for gene conversion. Hum Mutat. 2007 Mar. 28(3):255-64. [Medline].
Augoustides-Savvopoulou P, Luka Z, Karyda S, et al. Glycine N -methyltransferase deficiency: a new patient with a novel mutation. J Inherit Metab Dis. 2003. 26(8):745-59. [Medline].
Orendae M, Pronicka E, Kubalska J, et al. Identification and functional analysis of two novel mutations in the CBS gene in Polish patients with homocystinuria. Hum Mutat. 2004 Jun. 23(6):631. [Medline].
Whiteman P, Hutchinson S, Handford PA. Fibrillin-1 misfolding and disease. Antioxid Redox Signal. 2006 Mar-Apr. 8(3-4):338-46. [Medline].
Morel CF, Lerner-Ellis JP, Rosenblatt DS. Combined methylmalonic aciduria and homocystinuria (cblC): phenotype-genotype correlations and ethnic-specific observations. Mol Genet Metab. 2006 Aug. 88(4):315-21. [Medline].
Baumgartner ER, Wick H, Maurer R, et al. Congenital defect in intracellular cobalamin metabolism resulting in homocysteinuria and methylmalonic aciduria. I. Case report and histopathology. Helv Paediatr Acta. 1979. 34(5):465-82. [Medline].
Zavadakova P, Fowler B, Zeman J, et al. CblE type of homocystinuria due to methionine synthase reductase deficiency: clinical and molecular studies and prenatal diagnosis in two families. J Inherit Metab Dis. 2002 Oct. 25(6):461-76. [Medline].
Coelho D, Suormala T, Stucki M, et al. Gene identification for the cblD defect of vitamin B12 metabolism. N Engl J Med. 2008 Apr 3. 358(14):1454-64. [Medline].
Elshorbagy AK, Nurk E, Gjesdal CG, et al. Homocysteine, cysteine, and body composition in the Hordaland Homocysteine Study: does cysteine link amino acid and lipid metabolism?. Am J Clin Nutr. 2008 Sep. 88(3):738-46. [Medline].
Rummel T, Suormala T, Haberle J, et al. Intermediate hyperhomocysteinaemia and compound heterozygosity for the common variant c.677C>T and a MTHFR gene mutation. J Inherit Metab Dis. 2007 Jun. 30(3):401. [Medline].
Bishop L, Kanoff R, Charnas L, Krenzel C, Berry SA, Schimmenti LA. Severe methylenetetrahydrofolate reductase (MTHFR) deficiency: a case report of nonclassical homocystinuria. J Child Neurol. 2008 Jul. 23(7):823-8. [Medline].
Jakubowski H, Boers GH, Strauss KA. Mutations in cystathionine beta-synthase or methylenetetrahydrofolate reductase gene increase N-homocysteinylated protein levels in humans. FASEB J. 2008 Dec. 22(12):4071-6. [Medline].
Richard E, Desviat LR, Ugarte M, Pérez B. Oxidative stress and apoptosis in homocystinuria patients with genetic remethylation defects. J Cell Biochem. 2013 Jan. 114(1):183-91. [Medline].
Chang JT, Chen YY, Liu TT, Liu MY, Chiu PC. Combined methylmalonic aciduria and homocystinuria cblC type of a Taiwanese infant with c.609G>A and C.567dupT mutations in the MMACHC gene. Pediatr Neonatol. 2011 Aug. 52(4):223-6. [Medline].
Miroslav Janošík, Jitka Sokolová, Bohumila Janošíková, Jakub Krijt, Veronika Klatovská, Viktor Kožich. Birth Prevalence of Homocystinuria in Central Europe: Frequency and Pathogenicity of Mutation c.1105C>T (p.R369C) in the Cystathionine Beta-Synthase Gene. J Pediatr. 2009 March. 154(3):431–437.
Lu YH, Huang YH, Cheng LM, et al. Homocystinuria in Taiwan: an inordinately high prevalence in an Austronesian aboriginal tribe, Tao. Mol Genet Metab. 2012 Apr. 105(4):590-5. [Medline].
Lu YH, Cheng LM, Huang YH, Lo MY, Wu TJ, Lin HY, et al. Heterozygous carriers of classical homocystinuria tend to have higher fasting serum homocysteine concentrations than non-carriers in the presence of folate deficiency. Clin Nutr. 2014 Dec 3. pii: S0261-5614(14)00295-7:1-4. [Medline].
Alehan F, Saygi S, Gedik S, Kayahan Ulu EM. Stroke in early childhood due to homocystinuria. Pediatr Neurol. 2010 Oct. 43(4):294-6. [Medline].
Sarov M, Not A, de Baulny HO, Masnou P, Vahedi K, Bousser MG, et al. A case of homocystinuria due to CBS gene mutations revealed by cerebral venous thrombosis. J Neurol Sci. 2014 Jan 15. 336 (1-2):257-9. [Medline].
Goswami JN, Murthy TV, Singh D, Raj V. Cerebral sinovenous thrombosis in a child with homocystinuria. Med J Armed Forces India. 2015 Jul. 71 (Suppl 1):S39-42. [Medline].
Rahman T, Cole EF. Capgras syndrome in homocystinuria. Biol Psychiatry. 2014 Sep 15. 76 (6):e11-2. [Medline].
Colafrancesco G, Di Marzio GM, Abbracciavento G, Stoppioni V, Leuzzi V, Ferrara M. Acute psychosis in an adolescent with undiagnosed homocystinuria. Eur J Pediatr. 2015 Sep. 174 (9):1263-6. [Medline].
Shaker OG, El-Tahlawi SM. Is there a relationship between homocysteine and vitiligo? A pilot study. Br J Dermatol. 2008 Sep. 159(3):720-4. [Medline].
Tallur KK, Johnson DA, Kirk JM, et al. Folate-induced reversal of leukoencephalopathy and intellectual decline in methylene-tetrahydrofolate reductase deficiency: variable response in siblings. Dev Med Child Neurol. 2005 Jan. 47(1):53-6. [Medline].
Sato Y, Iwamoto J, Kanoko T, Satoh K. Homocysteine as a predictive factor for hip fracture in elderly women with Parkinson's disease. Am J Med. 2005 Nov. 118(11):1250-5. [Medline].
Hafidi Z, Berradi S, Handor H, Regragui A, Lezrek M, Daoudi R. Atypical presentation of ectopia lentis in homocystinuria. J Pediatr. 2015 Apr. 166 (4):1091. [Medline].
Gerth C, Morel CF, Feigenbaum A, Levin AV. Ocular phenotype in patients with methylmalonic aciduria and homocystinuria, cobalamin C type. J AAPOS. Dec 2008. 12(6):591-6. [Medline].
Gaillard MC, Matthieu JM, Borruat FX. Retinal dysfunction in combined methylmalonic aciduria and homocystinuria (Cblc) disease: a spectrum of disorders. Klin Monatsbl Augenheilkd. 2008 May. 225(5):491-4. [Medline].
Montalvo LA, Venincasa VD, Aziz HA, Hess D, Berrocal AM. FEVR-Like Presentation of Homocystinuria. Case Rep Ophthalmol Med. 2014. 2014:646351. [Medline].
O'Neill JL, Narahari S, Sane DC, Yosipovitch G. Cardiac manifestations of cutaneous disorders. J Am Acad Dermatol. 2013 Jan. 68(1):156-66. [Medline].
Goswami JN, Murthy SP, Singh D, Raj V. Cerebral sinovenous thrombosis in a child with homocystinuria. Med J Armed Forces India. 2013 Feb. 1-4.
D'Alessandro G, Tagariello T, Piana G. Oral and craniofacial findings in a patient with methylmalonic aciduria and homocystinuria: review and a case report. Minerva Stomatol. 2010 Mar. 59(3):129-37. [Medline].
James SJ, Cutler P, Melnyk S, et al. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr. 2004 Dec. 80(6):1611-7. [Medline].
Ichinohe A, Kanaumi T, Takashima S, Enokido Y, Nagai Y, Kimura H. Cystathionine beta-synthase is enriched in the brains of Down's patients. Biochem Biophys Res Commun. 2005 Dec 23. 338(3):1547-50. [Medline].
Wilcken DE, Wang J, Sim AS, et al. Asymmetric dimethylarginine in homocystinuria due to cystathionine beta-synthase deficiency: relevance of renal function. J Inherit Metab Dis. 2006 Feb. 29(1):30-7. [Medline].
Snyderman SE. Liver failure and neurologic disease in a patient with homocystinuria. Mol Genet Metab. 2006 Mar. 87(3):210-2. [Medline].
Diana Muacevic-Katanec, Tihomir Kekez, Ksenija Fumic, Ivo Baric, Marijan Merkler, Jasminka Jakic-Razumovic, et al. Spontaneous Perforation of the Small Intestine, a Novel Manifestation of Classical Homocystinuria in an Adult with New Cystathionine ß-synthetaseGene Mutations. Coll. Antropol. 2011, Mar. 35:181-185. [Medline].
Muacevic-Katanec D, Kekez T, Fumic K, et al. Spontaneous perforation of the small intestine, a novel manifestation of classical homocystinuria in an adult with new cystathionine beta-synthetase gene mutations. Coll Antropol. 2011 Mar. 35(1):181-5. [Medline].
Fowler B, Schutgens RB, Rosenblatt DS, et al. Folate-responsive homocystinuria and megaloblastic anaemia in a female patient with functional methionine synthase deficiency (cblE disease). J Inherit Metab Dis. 1997 Nov. 20(6):731-41. [Medline].
Febriani AD, Sakamoto A, Ono H, et al. Determination of total homocysteine in dried blood spots using high performance liquid chromatography for homocystinuria newborn screening. Pediatr Int. 2004 Feb. 46(1):5-9. [Medline].
Bártl J, Chrastina P, Krijt J, Hodík J, Pešková K, Kožich V. Simultaneous determination of cystathionine, total homocysteine, and methionine in dried blood spots by liquid chromatography/tandem mass spectrometry and its utility for the management of patients with homocystinuria. Clin Chim Acta. 2014 Nov 1. 437:211-7. [Medline].
Refsum H, Fredriksen A, Meyer K, et al. Birth prevalence of homocystinuria. J Pediatr. 2004 Jun. 144(6):830-2. [Medline].
Yamasaki-Yashiki S, Tachibana S, Asano Y. Determination of L-methionine using methionine-specific dehydrogenase for diagnosis of homocystinuria due to cystathionine ß-synthase deficiency. Anal Biochem. 2012 Sep 15. 428(2):143-9. [Medline].
Navratil T, Petr M, Senholdova Z, et al. Diagnostic significance of urinary thiodiglycolic acid as a possible tool for studying the role of vitamins B12 and folates in the metabolism of thiolic substances. Physiol Res. 2006 Feb 23. [Medline].
Sen S, Yu J, Yamanishi M, Schellhorn D, Banerjee R. Mapping peptides correlated with transmission of intrasteric inhibition and allosteric activation in human cystathionine beta-synthase. Biochemistry. 2005 Nov 1. 44(43):14210-6. [Medline].
Jakub Krijt, Jana Kopecká, Aleš Hnízda, Stuart Moat, Leo A. J. Kluijtmans, Philip Mayne, et al. Determination of cystathionine beta-synthase activity in human plasma by LC-MS/MS: potential use in diagnosis of CBS deficiency. J Inherit Metab Dis. 2011 February. 34(1):49–55.
Smith DE, Mendes MI, Kluijtmans LA, Janssen MC, Smulders YM, Blom HJ. A liquid chromatography mass spectrometry method for the measurement of cystathionine ß-synthase activity in cell extracts. J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Dec 12. 911:186-91. [Medline].
Chambers AE, McIntosh N, Al-Dirbashi OY, Chakraborty P. Homocysteine analysis in dried blood spots by LC–MS/MS as a second tier test for homocystinuria. Clin Biochem. Oct 2014. 47(15):140.
Scherer EB, Stefanello FM, Mattos C, Netto CA, Wyse AT. Homocysteine reduces cholinesterase activity in rat and human serum. Int J Dev Neurosci. 2007 Jun. 25(4):201-5. [Medline].
Debray FG, Boulanger Y, Khiat A, et al. Reduced brain choline in homocystinuria due to remethylation defects. Neurology. 2008 Jul 1. 71(1):44-9. [Medline].
Sosvorová L, Bešťák J, Bičíková M, Mohapl M, Hill M, Kubátová J, et al. Determination of homocysteine in cerebrospinal fluid as an indicator for surgery treatment in patients with hydrocefalus. Physiol Res. 2014 Sep 4. 63 (4):521-7. [Medline].
Longo D, Fariello G, Dionisi-Vici C, et al. MRI and 1H-MRS findings in early-onset cobalamin C/D defect. Neuropediatrics. 2005 Dec. 36(6):366-72. [Medline].
Poloni S, Schweigert Perry ID, D'Almeida V, Schwartz IV. Does phase angle correlate with hyperhomocysteinemia? A study of patients with classical homocystinuria. Clin Nutr. 2013 Jun. 32(3):479-80. [Medline].
Zong Y, Liu N, Zhao Z, Kong X. Prenatal diagnosis using genetic sequencing and identification of a novel mutation in MMACHC. BMC Med Genet. 2015 Jul 7. 16:48. [Medline].
Gahl WA, Bernardini I, Chen S, et al. The effect of oral betaine on vertebral body bone density in pyridoxine-non-responsive homocystinuria. J Inherit Metab Dis. 1988. 11(3):291-8. [Medline].
Lawson-Yuen A, Levy HL. The use of betaine in the treatment of elevated homocysteine. Mol Genet Metab. 2006 Jul. 88(3):201-7. [Medline].
Singh RH, Kruger WD, Wang L, et al. Cystathionine beta-synthase deficiency: effects of betaine supplementation after methionine restriction in B6-nonresponsive homocystinuria. Genet Med. 2004 Mar-Apr. 6(2):90-5. [Medline].
Sakamoto A, Sakura N. Limited effectiveness of betaine therapy for cystathionine beta synthase deficiency. Pediatr Int. 2003 Jun. 45(3):333-8. [Medline].
Yaghmai R, Kashani AH, Geraghty MT, et al. Progressive cerebral edema associated with high methionine levels and betaine therapy in a patient with cystathionine beta-synthase (CBS) deficiency. Am J Med Genet. 2002 Feb 15. 108(1):57-63. [Medline].
Liu Y, Wang Q, Li X, Ding Y, Song J, Yang Y. First Chinese case of successful pregnancy with combined methylmalonic aciduria and homocystinuria, cblC type. Brain Dev. 2015 Mar. 37 (3):286-91. [Medline].
Tada H, Takanashi J, Barkovich AJ, et al. Reversible white matter lesion in methionine adenosyltransferase I/III deficiency. AJNR Am J Neuroradiol. 2004 Nov-Dec. 25(10):1843-5. [Medline].
Bass HN, LaGrave D, Mardach R, Cederbaum SD, Fuster CD, Chetty M. Spontaneous pneumothorax in association with pyridoxine-responsive homocystinuria. J Inherit Metab Dis. 1997 Nov. 20(6):831-2. [Medline].
Zaidi SH, Faiyaz-Ul-Haque M, Shuaib T, et al. Clinical and molecular findings of 13 families from Saudi Arabia and a family from Sudan with homocystinuria. Clin Genet. 2012 Jun. 81(6):563-70. [Medline].
Kozich V, Sokolová J, Klatovská V, Krijt J, Janosík M, Jelínek K, et al. Cystathionine beta-synthase mutations: effect of mutation topology on folding and activity. Hum Mutat. 2010 Jul. 31(7):809-19. [Medline]. [Full Text].
Scriver CR, Beaudet AL, Sly WS. The Metabolic and Molecular Bases of Inherited Diseases. 7th ed. New York, NY: McGraw-Hill; 1995.
Lu YH, Cheng LM, Huang YH, Lo MY, Wu TJ, Lin HY, et al. Heterozygous carriers of classical homocystinuria tend to have higher fasting serum homocysteine concentrations than non-carriers in the presence of folate deficiency. Clin Nutr. 2014 Dec 3. 1-4. [Medline].